[{"id":"0778f69f-9b26-4fa2-8d42-2591932eddd2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05560035","created_at":"2022-09-29T15:56:59.742Z","updated_at":"2024-07-02T16:36:03.186Z","phase":"","brief_title":"The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery","source_id_and_acronym":"NCT05560035","lead_sponsor":"General Hospital of Ningxia Medical University","biomarkers":" MMP2 • VEGFC • MMP9 • THBS2","pipe":"","alterations":" ","tags":["MMP2 • VEGFC • MMP9 • THBS2"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 12/01/2022","start_date":" 12/01/2022","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2022-09-29"}]